نتائج البحث - "Dermatology & Venereal Diseases"

1

Malignancy Rates in Brodalumab Clinical Studies for Psoriasis

المؤلفون: Alice B. Gottlieb, Robert J. Israel, Clive Liu, Abby Jacobson, Mark Lebwohl

المصدر: American Journal of Clinical Dermatology

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Randomization, Adolescent, Brodalumab, Phases of clinical research, Dermatology, Antibodies, Monoclonal, Humanized, Placebo, Malignancy, Placebos, Young Adult, 030207 dermatology & venereal diseases, 03 medical and health sciences, Clinical Trials, Phase II as Topic, 0302 clinical medicine, Neoplasms, Psoriasis, Ustekinumab, medicine, Humans, Multicenter Studies as Topic, Original Research Article, Aged, Randomized Controlled Trials as Topic, Aged, 80 and over, Receptors, Interleukin-17, business.industry, General Medicine, Middle Aged, medicine.disease, United States, Clinical trial, Clinical Trials, Phase III as Topic, Female, Dermatologic Agents, business, Follow-Up Studies, SEER Program, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27ac875f96b4d804494e9249b16d7465Test
https://doi.org/10.1007/s40257-020-00512-4Test

2

Switching Biologics in the Treatment of Psoriasis: A Multicenter Experience

المؤلفون: Asude Kara Polat, Tuğba Özkök Akbulut, Ayse Serap Karadag, Filiz Topaloğlu Demir, İlknur Kıvanç Altunay, Sema Aytekin, Ezgi Özkur, İlteriş Oğuz Topal

المصدر: Dermatology. 237:22-30

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::946931fbf607423861492de92e38733dTest
https://doi.org/10.1159/000504839Test

3

Users of biologics in clinical practice: would they be eligible for phase III clinical studies? Cohort Study in the French Psoriasis Registry PSOBIOTEQ

المؤلفون: M. Masson Regnault, Denis Jullien, Pascal Joly, J. Castañeda‐Sanabria, Emilie Sbidian, M. Viguier, Alain Dupuy, Hervé Bachelez, M.H.T. Diep Tran, Olivier Chosidow, E. Mahé, Nathalie Beneton, Carle Paul, Marie Beylot-Barry, Florence Tubach, Marie Aleth Richard

المساهمون: Centre Hospitalier Universitaire de Reims (CHU Reims), Immuno-Régulation dans les Maladies Auto-Immunes Inflammatoires et le Cancer - EA 7509 (IRMAIC), Université de Reims Champagne-Ardenne (URCA)

المصدر: Journal of the European Academy of Dermatology and Venereology
Journal of the European Academy of Dermatology and Venereology, Wiley, 2020, 34 (2), pp.293-300. ⟨10.1111/jdv.15878⟩

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Adolescent, Brodalumab, Dermatology, law.invention, Cohort Studies, Young Adult, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Psoriasis, Internal medicine, Ustekinumab, medicine, Humans, Registries, Adverse effect, ComputingMilieux_MISCELLANEOUS, Aged, Aged, 80 and over, Biological Products, business.industry, Middle Aged, medicine.disease, 3. Good health, Clinical trial, Infectious Diseases, Clinical Trials, Phase III as Topic, 030220 oncology & carcinogenesis, Inclusion and exclusion criteria, Female, Dermatologic Agents, France, business, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, Cohort study, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cbf9fc8c7ba225d37cf09e7d025d4a4Test
https://doi.org/10.1111/jdv.15878Test

4

A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real‐world populations in psoriasis

المؤلفون: Yiu, ZZN, Mason, KJ, Barker, JNWN, Hampton, PJ, McElhone, K, Smith, CH, Warren, RB, Griffiths, CEM, Lunt, M, Burden, AD, Study Group, BADBIR

المصدر: The British Journal of Dermatology
Yiu, Z Z N, Mason, K J, Barker, J N W N, Hampton, P J, McElhone, K, Smith, C H, Warren, R B, Griffiths, C E M, Lunt, M & Burden, A D 2019, ' A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real-world populations in psoriasis ', British Journal of Dermatology . https://doi.org/10.1111/bjd.17849Test

مصطلحات موضوعية: Male, Q1, law.invention, Etanercept, 030207 dermatology & venereal diseases, 0302 clinical medicine, Randomized controlled trial, law, Registries, Randomized Controlled Trials as Topic, Aged, 80 and over, education.field_of_study, Incidence, R735, Middle Aged, Reference Standards, 3. Good health, Treatment Outcome, Research Design, Cohort, Female, Ustekinumab, medicine.drug, Adult, medicine.medical_specialty, Drug-Related Side Effects and Adverse Reactions, RL, Population, Dermatology, 03 medical and health sciences, Young Adult, Psoriasis Area and Severity Index, Psoriasis, Internal medicine, medicine, Humans, education, Aged, Biological Products, business.industry, Patient Selection, Adalimumab, Original Articles, medicine.disease, R1, Clinical trial, Logistic Models, Propensity score matching, Multivariate Analysis, General Dermatology, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::038c4f12ba259f0b976cbdefb61e60c1Test
http://europepmc.org/articles/PMC6916305Test

5

Ustekinumab no Tratamento de Psoríase Moderada a Grave: Experiência em 116 Doentes da Prática Clínica

المؤلفون: Andreia Bettencourt, Manuela Selores, Tiago Torres, Inês Raposo, Luiz Fernando Carvalho Leite

المصدر: Acta Médica Portuguesa; v. 32, n. 3 (2019): Março; 214-218
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
Acta Médica Portuguesa, Vol 32, Iss 3, Pp 214-218 (2019)

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Tuberculosis, Adolescent, lcsh:Medicine, Biological Products/therapeutic use, Psoriasis/drug therapy, Ustekinumab/therapeutic use, Biológicos/uso terapêutico, Psoríase/tratamento, Ustekinumab/uso terapêutico, Young Adult, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Ustekinumab, medicine, Adjuvant therapy, Humans, Psoriasis, In real life, Child, Adverse effect, Aged, lcsh:R5-920, business.industry, lcsh:R, Moderate to severe psoriasis, General Medicine, Middle Aged, medicine.disease, Clinical trial, Methotrexate, Treatment Outcome, Child, Preschool, 030220 oncology & carcinogenesis, Female, Dermatologic Agents, lcsh:Medicine (General), business, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dea94b874246c681e7cb1a7891b7b748Test
https://doi.org/10.20344/amp.10728Test

6

Efficacy and safety of brodalumab in patients with psoriasis who had inadequate responses to ustekinumab: subgroup analysis of two randomized phase III trials

المؤلفون: Mark Lebwohl, Andrew Blauvelt, Shipra Rastogi, Radhakrishnan Pillai, Robert J. Israel, April W. Armstrong, Sylvia Hsu, Stephen K. Tyring, Richard G. Langley

المصدر: British Journal of Dermatology. 180:306-314

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Adolescent, Brodalumab, Dermatology, Antibodies, Monoclonal, Humanized, Severity of Illness Index, law.invention, Young Adult, 030207 dermatology & venereal diseases, 03 medical and health sciences, Psoriatic arthritis, 0302 clinical medicine, Double-Blind Method, Randomized controlled trial, Psoriasis Area and Severity Index, law, Internal medicine, Psoriasis, Ustekinumab, Humans, Medicine, Adverse effect, Aged, Randomized Controlled Trials as Topic, Skin, Body surface area, business.industry, Remission Induction, Middle Aged, medicine.disease, Treatment Outcome, Clinical Trials, Phase III as Topic, Female, Dermatologic Agents, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b73152183edc65a2af5adba71b2b0719Test
https://doi.org/10.1111/bjd.17318Test

7

Longitudinal Study of the Psoriasis-Associated Skin Microbiome during Therapy with Ustekinumab in a Randomized Phase 3b Clinical Trial

المؤلفون: Michael A. Loesche, Kamyar Farahi, Elizabeth A. Grice, Amanda S. Tyldsley, Samuel E. DePrimo, Marc Chevrier, Carrie Brodmerkel, Joseph Horwinski, Kristina Callis Duffin, Steven Fakharzadeh, Kimberly A. Capone, Kevin D. Smith, Andrew Blauvelt, Ernesto J. Muñoz-Elías, Bidisha Dasgupta

المصدر: Journal of Investigative Dermatology. 138:1973-1981

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f00d2703afa3180542f5b6f3ad25635Test
https://doi.org/10.1016/j.jid.2018.03.1501Test

8

Using Real-World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study

المساهمون: Landsteiner Laboratory, AII - Inflammatory diseases

المصدر: CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 13(2), 400-409. Wiley-Blackwell
Clinical and Translational Science, Vol 13, Iss 2, Pp 400-409 (2020)
Clinical and Translational Science
Pan, S, Tsakok, T, Dand, N, Lonsdale, D O, Loeff, F C, Bloem, K, de Vries, A, Baudry, D, Duckworth, M, Mahil, S, Pushpa-Rajah, A, Russell, A, Alsharqi, A, Becher, G, Murphy, R, Wahie, S, Wright, A, Griffiths, C E M, Reynolds, N J, Barker, J, Warren, R B, David Burden, A, Rispens, T & Standing, J F & Smith, C H 2020, ' Using Real-World Data to Guide Ustekinumab Dosing Strategies for Psoriasis : A Prospective Pharmacokinetic-Pharmacodynamic Study ', Clinical and Translational Science, vol. 13, no. 2, pp. 400-409 . https://doi.org/10.1111/cts.12725Test, https://doi.org/10.1111/cts.12725Test
Pan, S, Tsakok, T, Dand, N, Lonsdale, D O, Loeff, F C, Bloem, K, de Vries, A, Baudry, D, Duckworth, M, Mahil, S, Pushpa-Rajah, A, Russell, A, Alsharqi, A, Becher, G, Murphy, R, Wahie, S, Wright, A, Griffiths, C E M, Reynolds, N J, Barker, J, Warren, R B, David Burden, A, Rispens, T, Standing, J F, Smith, C H, Benham, M, Evans, I, Hussain, S, Kirby, B, Lawson, L, Mason, K, McElhone, K, Ormerod, A, Owen, C, Barnes, M R, Di Meglio, P, Emsley, R, Evans, A & Payne, K 2020, ' Using Real-World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study ', Clinical and Translational Science, vol. 13, no. 2, pp. 400-409 . https://doi.org/10.1111/cts.12725Test

مصطلحات موضوعية: Oncology, Male, 030226 pharmacology & pharmacy, Severity of Illness Index, 030207 dermatology & venereal diseases, 0302 clinical medicine, Drug Dosage Calculations, Prospective Studies, General Pharmacology, Toxicology and Pharmaceutics, Prospective cohort study, media_common, medicine.diagnostic_test, General Neuroscience, lcsh:Public aspects of medicine, R735, General Medicine, Articles, Middle Aged, 3. Good health, Treatment Outcome, Female, Ustekinumab, Drug Monitoring, medicine.drug, Drug, Adult, medicine.medical_specialty, RM, Adolescent, media_common.quotation_subject, Injections, Subcutaneous, RL, Models, Biological, General Biochemistry, Genetics and Molecular Biology, Article, 03 medical and health sciences, Young Adult, Pharmacokinetics, Psoriasis, Internal medicine, medicine, Humans, Dosing, Aged, business.industry, Research, lcsh:RM1-950, Bayes Theorem, lcsh:RA1-1270, medicine.disease, R1, lcsh:Therapeutics. Pharmacology, Therapeutic drug monitoring, Pharmacodynamics, Dermatologic Agents, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bcea23ca63518fef3372a4c62f0df85Test
https://pure.amc.nl/en/publications/using-realworld-data-to-guideTest-ustekinumab-dosing-strategies-for-psoriasis(356fdda6-87b8-4fbc-8cc1-218c18c81fd8).html

9

The Presence of HLA-A Bw4-80I KIR Ligands Could Predict 'Difficult-to-Treat' Psoriasis and Poor Response to Etanercept

المؤلفون: Raffaello Cananzi, Catherine Klersy, Rosalia Cacciatore, I. Sbarsi, Annamaria Pasi, Valeria Brazzelli, M. Guarene, Vittorio Bolcato, A. Piccolo

المصدر: Molecular Diagnosis & Therapy. 22:471-474

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30d244845c74222ade56d568eb536429Test
https://doi.org/10.1007/s40291-018-0345-9Test

10

Infectious risk of biological drugs vs. traditional systemic treatments in moderate-to-severe psoriasis: a cohort analysis in the French insurance database

المؤلفون: Robert Bourrel, Jean-Louis Montastruc, Sylvain Couderc, Agnès Sommet, Maryse Lapeyre-Mestre, Carle Paul

المصدر: Fundamental & Clinical Pharmacology. 32:436-449

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24872ceeda9185c9a4e8798d8033e85eTest
https://doi.org/10.1111/fcp.12358Test

تنقيح النتائج